Abel Hall LLC’s Organon & Co OGN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q4
Sell
-20,908
Closed -$223K 730
2025
Q3
$223K Sell
20,908
-1,528
-7% -$15K 0.09% 244
2025
Q2
$217K Buy
22,436
+10,952
+95% +$113K 0.1% 218
2025
Q1
$171K Buy
11,484
+433
+4% +$6.66K 0.1% 168
2024
Q4
$165K Sell
11,051
-58
-0.5% -$945 0.11% 139
2024
Q3
$213K Sell
11,109
-12
-0.1% -$249 0.14% 129
2024
Q2
$230K Buy
11,121
+107
+1% +$2.13K 0.16% 107
2024
Q1
$207K Buy
+11,014
New +$189K 0.15% 118

Other funds holding OGN

Abel Hall LLC's OGN Position: Q4 2025 in Review

Abel Hall LLC sold out of Organon & Co (OGN) in Q4 2025, closing a stake of 20,908 shares — an estimated $223K sold.

Abel Hall LLC first reported a position in OGN in Q1 2024 and held it in 7 quarters. The position peaked at $230K in Q2 2024. 634 funds tracked by Wall St. Rank hold OGN as of Q4 2025.

  • Abel Hall LLC reported no remaining Organon & Co position as of Q4 2025 after selling out during the quarter.
  • Abel Hall LLC sold 20,908 Organon & Co shares in Q4 2025, an estimated $223K.
  • Abel Hall LLC first reported a position in Organon & Co in Q1 2024 and held it in 7 quarters.
  • Abel Hall LLC's Organon & Co position peaked at $230K in Q2 2024.
  • 634 funds tracked by Wall St. Rank held Organon & Co as of Q4 2025.

Based on Abel Hall LLC's 13F filing for Q4 2025, filed 17 Feb 2026.